Tokyo, Japan

Kiyoshi Mizuguchi

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 87(Granted Patents)


Company Filing History:


Years Active: 1995-2019

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Kiyoshi Mizuguchi: Innovative Solutions for Non-Alcoholic Steatohepatitis

Introduction

Kiyoshi Mizuguchi is a prominent inventor based in Tokyo, Japan, recognized for his significant contributions to medical technology and pharmaceuticals. With a total of 8 patents to his name, he continues to address critical health concerns, particularly in the treatment of liver diseases.

Latest Patents

One of Mizuguchi's notable patents is focused on compositions and methods for treating non-alcoholic steatohepatitis (NASH). This groundbreaking disclosure outlines a method for treating fatty liver disorders in subjects, specifically targeting those who are non-diabetic, pre-diabetic, mildly diabetic, or have normal biliary tract function. His method involves administering a therapeutically effective amount of a pharmaceutical composition that comprises ethyl eicosapentanoate (EPA-E), which may represent at least 40% by weight of the total fatty acids and their derivatives. Another important patent by Mizuguchi involves compositions and methods utilizing ethyl icosapentate for treating NASH, further showcasing his commitment to advancing liver disease treatment options.

Career Highlights

Mizuguchi's work at Mochida Pharmaceutical Co., Ltd. has been instrumental in developing innovative therapies that aim to improve patient outcomes. His extensive research and patent portfolio demonstrate his dedication to finding solutions for complex health issues, particularly in hepatology.

Collaborations

Throughout his career, Mizuguchi has collaborated with various professionals in the field, including colleagues such as Tsuyoshi Harada and Shuhei Ohnishi. These collaborative efforts have contributed to the progress and evolution of his research in liver disease treatments.

Conclusion

Kiyoshi Mizuguchi stands out as an influential inventor in the pharmaceutical industry, with a focus on treating non-alcoholic fatty liver diseases. His ongoing research and innovations are expected to play a pivotal role in alleviating the burden of liver disorders, marking him as a significant figure in medical advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…